Artwork

Content provided by Gil Porat, M.D., FACP, CPT, Gil Porat, M.D., FACP, and CPT. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Gil Porat, M.D., FACP, CPT, Gil Porat, M.D., FACP, and CPT or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Type 2 Diabetes Treatment - Part 7 - GLP-1 Agonists and DPP-4 Inhibitors

16:46
 
Share
 

Manage episode 230820991 series 2499394
Content provided by Gil Porat, M.D., FACP, CPT, Gil Porat, M.D., FACP, and CPT. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Gil Porat, M.D., FACP, CPT, Gil Porat, M.D., FACP, and CPT or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Glucagon-Like Peptide 1 (GLP-1) mimetics are also referred to as the GLP-1 receptor agonists. While this talk mostly focuses on GLP-1 mechanisms and actions, the hope is you will also better understand The Dipeptidyl Peptidase-4 (DPP-4) inhibitors

The current GLP-1 Agonists include Exenatide (Byetta), Liraglutide (Victoza), Dulaglutide (Trulicity), Abiglutide (Tanzeum), Lixisenatide (Adlyxin), Semaglutide (Ozempic).

The current DPP-4 Inhibitors include Alogliptin (Nesina), Linagliptin (Tradjenta), Saxagliptin (Onglyza), Sitagliptin (Januvia).

  continue reading

130 episodes

Artwork
iconShare
 
Manage episode 230820991 series 2499394
Content provided by Gil Porat, M.D., FACP, CPT, Gil Porat, M.D., FACP, and CPT. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Gil Porat, M.D., FACP, CPT, Gil Porat, M.D., FACP, and CPT or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Glucagon-Like Peptide 1 (GLP-1) mimetics are also referred to as the GLP-1 receptor agonists. While this talk mostly focuses on GLP-1 mechanisms and actions, the hope is you will also better understand The Dipeptidyl Peptidase-4 (DPP-4) inhibitors

The current GLP-1 Agonists include Exenatide (Byetta), Liraglutide (Victoza), Dulaglutide (Trulicity), Abiglutide (Tanzeum), Lixisenatide (Adlyxin), Semaglutide (Ozempic).

The current DPP-4 Inhibitors include Alogliptin (Nesina), Linagliptin (Tradjenta), Saxagliptin (Onglyza), Sitagliptin (Januvia).

  continue reading

130 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide